Gyre Therapeutics, Inc.

General ticker "GYRE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $709.7M (TTM average)

Gyre Therapeutics, Inc. follows the US Stock Market performance with the rate: 0.8%.

Estimated limits based on current volatility of 2.6%: low 5.91$, high 6.22$

Factors to consider:

  • Total employees count: 5 as of 2024
  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [3.81$, 9.58$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.98$, 9.70$]

Financial Metrics affecting the GYRE estimates:

  • Positive: with PPE of 48.0 at the end of fiscal year the price was low
  • Positive: 7.60 < Operating profit margin, % of 9.85
  • Positive: 1.85 < Return on assets ratio (scaled to [-100,100]) of 5.61
  • Negative: negative Industry operating cash flow (median)
  • Negative: Inventory ratio change, % of 2.49 > 0.80
  • Negative: Industry earnings per price (median), % of -12.76 <= 0
  • Negative: 42.58 < Shareholder equity ratio, % of 63.82 <= 64.15

Similar symbols

Short-term GYRE quotes

Long-term GYRE plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $110.11MM $105.69MM $116.58MM
Operating Expenses $177.34MM $89.53MM $105.10MM
Operating Income $-67.23MM $16.16MM $11.49MM
Non-Operating Income $-9.73MM $7.05MM $2.95MM
R&D Expense $96.88MM $12.02MM $13.70MM
Income(Loss) $-76.97MM $23.22MM $14.44MM
Taxes $8.52MM $5.32MM $4.56MM
Profit(Loss)* $-92.93MM $12.09MM $5.03MM
Stockholders Equity $-15.83MM $63.32MM $106.03MM
Inventory $4.28MM $6.34MM $10.17MM
Assets $116.54MM $125.41MM $166.13MM
Operating Cash Flow $25.89MM $-3.64MM $1.01MM
Capital expenditure $8.59MM $3.13MM $1.19MM
Investing Cash Flow $-19.76MM $-19.88MM $-0.47MM
Financing Cash Flow $2.50MM $2.10MM $24.38MM
Earnings Per Share** $-1.41 $0.14 $0.06

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.